Size frequency distribution of prion protein (PrP) aggregates in variant Creutzfeldt-Jakob disease (vCJD)

Journal of Neural Transmission

Volumn 112, Issue 11, 2005, Pages 1565-1573

  Armstrong, R A ^a   Cairns, N J ^b   Ironside, J W ^c   Lantos, P L ^d  

^a ASTON UNIVERSITY   (United Kingdom)

^b WASHINGTON UNIVERSITY   (United States)

^c WESTERN GENERAL HOSPITAL   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

amyloid; Alzheimer's disease (AD); Diffuse plaque; Florid plaque; Log normal distribution; Prion protein (PrP) aggregate; Size distribution; Variant Creutzfeldt Jakob disease (vCJD)

Indexed keywords

AMYLOID BETA PROTEIN; PRION PROTEIN;

ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DOWN SYNDROME; HUMAN; HUMAN TISSUE; NEUROFIBRILLARY TANGLE; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE;

ADOLESCENT; ADULT; ALZHEIMER DISEASE; BRAIN; CREUTZFELDT-JAKOB SYNDROME; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, NEUROLOGICAL; NEUROPIL; PRIONS; SENILE PLAQUES; STATISTICAL DISTRIBUTIONS;

EID: 27144510914     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-005-0296-2     Document Type: Article

References (24)

1. RA Armstrong 1999 Do β-amyloid (Aβ) deposits in patients with Alzheimer's disease and Down's syndrome grow according to the log-normal model? Neurosci Lett 261 97 100
2. RA Armstrong 2001 Size frequency distribution of β-amyloid (Aβ) deposits in dementia with Lewy bodies. Alz Rep 4 167 172
3. RA Armstrong D Myers CUM Smith 1991 Alzheimer's disease: size frequency distribution of senile plaques: do they indicate when a brain region was affected? Neurosci Lett 127 223 226
4. RA Armstrong D Myers CUM Smith 1997 Factors determining the size frequency distribution of β-amyloid (Aβ) deposits in Alzheimer's disease. Exp Neurol 145 574 579
5. RA Armstrong PL Lantos NJ Cairns 2001 The spatial patterns of prion protein deposits in Creutzfeldt-Jakob disease: comparison with β-amyloid deposits in Alzheimer's disease. Neurosci Lett 298 53 56
6. RA Armstrong PL Lantos JW Ironside NJ Cairns 2003a Differences in the density and spatial distribution of florid and diffuse plaques in variant Creutzfeldt-Jakob disease (vCJD). Clin Neuropathol 22 209 214
7. RA Armstrong NJ Cairns JW Ironside PL Lantos 2003b Laminar distribution of the pathological changes in the cerebral cortex in variant Creutzfeldt-Jakob disease (vCJD). Folia Neuropathol 40 165 171
8. RA Armstrong NJ Cairns JW Ironside PL Lantos 2003c Florid prion protein (PrP) plaques in patients with variant Creutzfeldt-Jakob disease (vCJD) are spatially related to blood vessels. Neurosci Res Commun 32 29 36
9. FM Benes JL Reifel RE Majocha CA Marotta 1989 Evidence for a diffusional model of Alzheimer amyloid A4 (β amyloid) deposition during neuritic plaque formation. Neuroscience 33 483 488
10. V Grigoriev F Escarg-Haye N Streichenberger N Kopp J Langeveld P Brown JG Fournier 1999 Submicroscopic immunodetecteion of prion protein in the brain of a patient with new variant Creutzfeldt-Jakob disease. Neurosci Lett 264 57 60
11. JA Hainfellner J Aanschutz K Jellinger PP Liberski F Gullotta H Budka 1998 Coexistence of Alzheimer type neuropathology in Creutzfeldt-Jakob disease. Acta Neuropathol 96 116 122
12. AF Hill RJ Butterworth S Joiner G Jackson MN Rossor DJ Thomas A Frosh N Tolley JE Bell M Spencer A King S Al-Sarraj JW Ironside PL Lantos J Collinge 1999 Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 353 183 189
13. BT Hyman L West GW Rebeck RN Buldyrev M Mantegna M Ukleja S Harlin HE Stanley 1995 Quantitative analysis of senile plaques in Alzheimer's disease: observation of log-normal size distributions associated with apolipoprotein E genotype and trisomy 21 (Down's syndrome). Proc Natl Acad Sci USA 92 3586 3590
14. JW Ironside 2000 Pathology of variant Creutzfeldt-Jakob disease. Arch Virol [Suppl] 16 143 151
15. JW Ironside K Sutherland JE Bell L McCardle C Barrie K Estebeiro M Zeidler RG Will 1996 A new variant of Creutzfeldt-Jakob disease: neuropathological and clinical features. Cold Sp Hb Quant Biol LXI 523 530
16. JW Ironside MW Head JE Bell L McCardle RG Will 2000 Laboratory diagnosis of variant Creutzfeldt-Jakob disease. Histopathol 37 1 9
17. S Krasemann MH Groschup L Harmeyer G Hunsmann W Bodemer 1996 Generation of monoclonal antibodies against human prion proteins in PrPO/O mice. Mole Med 2 725 734
18. P Kuner B Bohrmann LO Tjernberg J Naslund G Huber S Celenk F Gruninger-Leitch JG Richards R Jakob-Roetne JA Kemp C Nordstedt 2000 Controlling polymerization of beta-amyloid and prion-derived protein with synthetic small molecular ligands. J Biol Chem 275 1673 1678
19. GY Li P Zhou ZZ Shao X Xie X Chen HH Wang LJ Chunyu TY Yu 2001 The natural silk spinning process - a nucleation-dependent aggregation mechanism. Eur J Biochem 268 6600 6606
20. CA McLean JW Ironside MP Alpers PW Brown L Cervenakova RMD Anderson CL Masters 1998 Comparative neuropathology of kuru with new variant of Creutzfeldt-Jakob disease: evidence for strain of agent predominating over genotype of host. Brain Pathol 8 429 437
21. JH Pollard 1979 Numerical and statistical techniques. Cambridge University Press Cambridge 97
22. HE Stanley SV Buldyrev L Cruz T Gomez-Isla S Havlin BT Hyman R Knowles B Urbanc C Wyart 1998 Statistical physics and Alzheimer's disease. Physica A 249 460 471
23. B Urbanc L Cruz SV Buldyrev S Havlen MC Irizarry HE Stanley BT Hyman 1999 Dynamics of plaque formation in Alzheimer's disease. Biophys J 76 1330 1334
24. RG Will JW Ironside M Zeidler SN Cousins K Estebeiro A Alperovitch S Poser M Pocchiari A Hofman PG Smith 1996 A new variant of Creutzfeldt-Jakob disease in the United Kingdom. Lancet 347 921 925